.

Swing Trade Idea – November 30, 2021

Market Setup

•Global markets are weak with USA red, Europe red, Japan red, Hong Kong red, China red, Asia red

•Yield curve steeper with longer duration rates rising

•US dollar lower relative to yen and Euro

News: Covid Omicron concerns are back as the virus spreads and MRNA CEO predicted a material drop in vaccine effectiveness and will take months to develop a new one. The health impact of Omicron is still TBD  Econ: Chicago PMI 9:45ET; Powell and Yellen speaking;  China PMI exceeded expectations; CAD GDP premarket

•Stocks: PFE higher on Omicron; MOLN announced their drug works on Covid mutations- verifying against Omicron; ZM/PTON/NFLX getting the lockdown bid; AU GFI bid in the premarket; CRM reporting after the close

•Indices: USA and world indices are risk-off. USA indices are all down with QQQ leading and IWM lagging. Large cap tech is the safety trade and AMZN is leading.  Price is between overnight high and low and these levels can be used for long/short decision making.

•Sectors: Leading: yen TLT Gold Lagging: natgas financials energy smallcaps bitcoin materials industrials

•Stocks to watch: 

PFE TLT ZM GFI MRNA Spec Names: MOLN VIR

Movers

Earnings BNS BZUN JKS MOMO TIGR

Indices /Yen TLT Gold UNG XLF XLE IWM bitcoin XLB XLI TAN DIA XRT SPY

S&P500 PFE NEM ETSY NFLX CLX MRNA INTU OXY CCL AAL OKE HES UAL EOG MAR LVS

Movers TIGR PFE PTON ARRY JKS BZUN BNTX MRNA UNG INTU SEDG REGN DLTR STLA GS

WSB  SNDL PLUG CLF BA SKLZ CLNE AMC GOEV CLOV CCJ SDC F RIOT

Trade Idea MOLN:

Molecular Partners is a Swiss based biotech reports it’s ensovibep, a tri-specific antiviral targeting the spike protein of SARS-CoV-2, maintains full potency against the individual positions of relevance to ensovibep that are mutated in the Omicron variant. VIR is another biotech moving with Omicron concerns. Caveat biotech is risky!